InvestorsHub Logo
Post# of 173885
Next 10
Followers 391
Posts 16955
Boards Moderated 0
Alias Born 10/23/2007

Re: StockRoomBully post# 69674

Friday, 07/20/2018 7:46:18 PM

Friday, July 20, 2018 7:46:18 PM

Post# of 173885
StockRoomBully! THATS A MUST WATCH $RDGL VIDO! WOW!! Thanks!

Vivos: Developing Innovative Technology to Destroy Cancerous Tumors



Published on Mar 7, 2018
Vivos Inc. (OTC: RDGL) is a Kennewick, Washington-based late stage development company, engaged in the development of a brachytherapy device for the treatment of cancerous tumors. Brachytherapy uses radiation to destroy tumors by placing a radioactive isotope inside the treatment area. Currently, the company is pursuing FDA approval of its brachytherapy device, RadioGel, initially for the treatment of advanced basal and squamous skin cancers. Concurrently, the Company is pursuing development of veterinary applications for a range of cancers in collaboration with four leading university veterinary hospitals. Veterinary applications should have a faster path to revenue for RDGL, while providing data supporting the safety and therapeutic effectiveness of RadioGel. RDGL's RadioGel requires no pre-market approval for pet therapy and the Company plans to generate near term revenue from veterinarian clinics and international licensing by 1Q18.

Please do not take any information I post here as investment advice on whether to buy, hold or sell a stock or any security. Please always do your own research. It is your responsibility alone on how to invest your own money.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News